Icon Legend

This session is not in your favorites.

This session is in your favorites. Click again to remove it.

Presentation Icons

Live Stream Sessions

Type here to filter the list

Saturday, Oct 19th
8:15 AM - 9:15 AM
AM24-ST-01-L - The Use of HLA-Typed Cellular Transfusions and/or Infusions for In Vivo Adsorption of Donor-Specific HLA Antibodies (DSAs) as a Desensitization Strategy for Hematopoietic Stem Cell Transplant Patients
Location: 320
Speaker: Deanna C. Fang, MD – UC San Diego School of Medicine
Speaker: Stefan Ciurea, MD – UNIVERSITY OF CALIFORNIA, IRVINE
Program Chair: Minh-Ha Tran, DO – AABB Member
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Saturday, Oct 19th
9:45 AM - 10:45 AM
AM24-ST-09-L - Sterility Testing for Cellular Therapies: Updates and Challenges. What should we be doing?
Location: 320
Program Chair: J. Wade Atkins, MS, MLS, SBB, CQA, CABP(H) – NIH/CC/DTM
Speaker: Dr. Anna Lau, PhD, D(ABMM) (she/her/hers) – NIH/CC/DLM
Speaker: Elizabeth Lessey-Morillon, PhD, RAC (she/her/hers) – Center for Biologics Evaluation and Research; Office of Therapeutic Products; Office of Cellular Therapy & Human Tissue CMC; U.S. Food and Drug Administration
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Saturday, Oct 19th
11:15 AM - 12:15 PM
AM24-ST-15-L - Sickle Cell Disease Psychosocial Support and Advocacy
Location: 320
Program Chair: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
Speaker: Yvette C. Tanhehco, MD, PhD, MS, CABP(AABB) – Department of Pathology and Cell Biology, Columbia University Irving Medical Center
Speaker: Adrienne Shapiro (she/her/hers) – Axis Advocacy
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Saturday, Oct 19th
11:15 AM - 12:15 PM
AM24-ST-20-L - Enhancing Laboratory Competency with AI: Meeting AABB Standards for Cell Processing Facilities and Blood Banks
Location: Grand Ballroom B
Program Chair: WANXING CUI, PhD – MedStar Georgetown University Hospital
Speaker: Daisy Annette, MLS (ASCP) SBB – Our Blood Institute
Speaker: Jyotiska Biswas – ThinkTrends
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Saturday, Oct 19th
1:45 PM - 2:45 PM
AM24-ST-21-L - Critical Role of an Assay Lifecycle in Analytical Development for Cell and Gene Therapy Products
Location: 320
Program Chair: Scott Jones, PhD (he/him/his) – BioBridge Global
Speaker: Scott Jones, PhD (he/him/his) – BioBridge Global
Speaker: Brent Morse, MS – Dark Horse Consulting Group
Speaker: Emmanuel Casasola (he/him/his) – BioBridge Global
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Sunday, Oct 20th
8:15 AM - 9:15 AM
AM24-SN-01-L - The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells
Location: 320
Program Chair: Wen Lu, MD – Mayo Clinic
Speaker: Jacques Galipeau, MD – University of Wisconsin in Madison
Speaker: Michael P. Gustafson, PhD – Mayo Clinic in Arizona
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Sunday, Oct 20th
8:15 AM - 9:15 AM
AM24-SN-06-L - Operationalizing Delivery of Gene Therapy for Sickle Cell Disease
Location: 342
Speaker: Stella Chou, MD (she/her/hers) – Children's Hospital of Philadelphia, University of Pennsylvania
Speaker: Yan Zheng, MD/PhD (she/her/hers) – St. Jude Children's Research Hospital
Speaker: Janet Kwiatkowski, MD, MSCE – CHOP
Program Chair: Ryan A. Metcalf, MD – ARUP Labs and Utah School of Medicine
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Sunday, Oct 20th
9:30 AM - 11:00 AM
PL2-SN-27 - ADAMTS13-Chimeric Auto-Antigen Receptor (CAAR) T cells To Target Autoreactive B cells As A Treatment For Immune-mediated Thrombotic Thrombocytopenic Purpura
Presenting Author: Roman H. Khadka, PhD – University of Pennsylvania
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Sunday, Oct 20th
9:30 AM - 11:00 AM
PL4-SN-27 - Freeze-Dried Platelets Decrease Bleeding in Refractory Thrombocytopenic Patients with Hematological Malignancies
Presenting Author: Maro Ohanian, DO – MD Anderson Cancer Center
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Sunday, Oct 20th
9:30 AM - 11:00 AM
PL5-SN-27 - Genetic Engineering of Megakaryocytes From Blood Progenitor Cells Using mRNA Lipid Nanoparticles
Presenting Author: Jerry Leung, PhD (he/him/his) – University of British Columbia
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Sunday, Oct 20th
2:00 PM - 3:00 PM
AM24-SN-09-L - Lesson's Learned Onboarding Cell and Gene Therapy Vendors and Clients in the 21st Century
Location: Grand Ballroom B
Program Chair: Kevin J. Land, MD – Vitalant
Speaker: Melissa Marlowe, CHS, MBA – Vitalant
Speaker: Kate Brown, PhD (she/they) – CooperSurgical, Inc.
Speaker: Laura Staller, MHA, MLS(ASCP) – NMDP
Speaker: Robert Marriott – Vitalant
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Sunday, Oct 20th
3:30 PM - 5:00 PM
AM24-SN-19-L - Viral Vector Systems and Cellular Therapy
Location: Grand Ballroom C
Program Chair: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
Speaker: Patrick Conley, MS, CBSP, NREMT (he/him/his) – Merrick and Company
Speaker: Anderson Reuben, PE, LEED AP – Merrick
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Monday, Oct 21st
8:15 AM - 9:15 AM
AM24-MN-01-L - Source Plasma for Further Manufacture and Transfusion Medicine – Finding Common Ground
Location: 320
Speaker: Toby Simon, MD (he/him/his) – Self employed
Speaker: James Knowles, PhD (he/him/his) – Plasma Protein Therapeutics Association
Program Chair: Michelle Fransen, MPH, MPS (she/her/hers) – Plasma Protein Therapeutics Association
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Monday, Oct 21st
9:45 AM - 10:45 AM
AM24-MN-09-L - Management of Hematotoxicity from Immune Effector Cell Therapy and Sickle Cell Disease Gene Therapy
Location: 320
Program Chair: Patricia Shi, MD (she/her/hers) – New York Blood Center
Speaker: Alexis Leonard, MD (she/her/hers) – St. Jude Children's Research Hospital
Speaker: Sara K. Silbert, MD, M.H.Sc (she/her/hers) – NIH
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
Monday, Oct 21st
9:45 AM - 10:45 AM
OA3-AM24-MN-14 - Comparative Analysis of Room Temperature (RT) Day 7 and Cold Storage (CS) Day 21 Platelets: An Interim Evaluation of the Chilled Platelet Study in vitro (CHIPSiv)
Location: 332
Presenting Author: Irona Khandaker, MBBS, PhD – University of Pittsburgh
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Monday, Oct 21st
9:45 AM - 10:45 AM
OA4-AM24-MN-14 - Impact Of P38 Mitogen Activated Protein Kinase And Minocycline On Platelets Stored At Cold Temperature For 21 Days
Location: 332
Presenting Author: Andrey Skripchenko, PhD (he/him/his) – FDA
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Monday, Oct 21st
9:45 AM - 10:45 AM
OA4-AM24-MN-15 - Incidence and Prevalence of Red Blood Cell Antibodies and Their Clinical Implications in Allogeneic Hematopoietic Stem Cell Transplantation: A BEST Collaborative Study
Location: 362
Presenting Author: Valery Kogler, MD – University of Virginia Health
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Monday, Oct 21st
3:30 PM - 5:00 PM
AM24-MN-26-L - Overview of Cell-Based Biologics Manufacturing as a Contracted Service
Location: 320
Program Chair: Christie Malone, MT(ASCP)SBB, CABP – GenCure
Speaker: Lee Buckler, JD (he/him/his) – Blood Centers of America
Speaker: Rogelio Zamilpa, PhD – GenCure
Speaker: Sanjin Zvonic, PhD (he/him/his) – Dark Horse Consulting Group
Speaker: Dominic Clarke, PhD – Cryoport Systems
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Monday, Oct 21st
3:30 PM - 5:00 PM
AM24-MN-30-L - Solve It! Scenarios in Apheresis and Cellular Therapy
Location: Grand Ballroom A
Program Chair: Vasiliki E. Kalodimou, Professor Dr. CABP (H), IARMES (she/her/hers) – IASO Materbity & Research Hospital & EUC
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Monday, Oct 21st
3:30 PM - 5:00 PM
AM24-MN-31-L - Cell Therapy: Creative Inventory Management & Discard
Location: 342
Program Chair: Brenda Alder, MS, MLS(ASCP)SBB, CABPH(AABB) (she/her/hers) – Northside Hospital Atlanta
Speaker: Jennifer Westerman, MT(ASCP) (she/her/hers) – Northside Hospital Atlanta
Speaker: Rupal Brahmbhatt, MLS (AMT), CABP (AABB) – Northside Hospital Atlanta
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Tuesday, Oct 22nd
8:30 AM - 10:00 AM
AM24-TU-01-L - Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies
Location: 320
Program Chair: Indira Guleria, PhD, D(ABHI), CABP(H) – BIDMC and Harvard Medical School
Speaker: Kate Rochlin, PhD (she/her/hers) – In8Bio
Speaker: Rafet Basar, MD – MD Anderson
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Tuesday, Oct 22nd
8:30 AM - 10:00 AM
AM24-TU-06-L - Oral Abstract - Biotherapy Spotlight
Location: 342
Program Chair: David Stroncek, MD – National Institutes of Health
Biotherapies, Cellular Therapies, and Immunotherapies
CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
Tuesday, Oct 22nd
8:30 AM - 10:00 AM
OA2-AM24-TU-06 - Developing An Engineered T Cell Therapy To Eliminate Inhibitors In Hemophilia A
Location: 342
Presenting Author: Morgan Hresko, BS, MS – Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero
Tuesday, Oct 22nd
8:30 AM - 10:00 AM
OA4-AM24-TU-06 - Rapid Isolation of CD4+ T Cells Using a Functionally Closed Microfluidic System for Generating Induced Regulatory T Cells for Adoptive Therapy
Location: 342
Presenting Author: Sergey S. Shevkoplyas, PhD – University of Houston
Biotherapies, Cellular Therapies, and Immunotherapies
CE: Zero